EQT AB

EQT

Equity

ISIN SE0012853455 / Valor 50056018

NASDAQ Nordic Exchange Stockholm, Equities (2024-12-23)

SEK 302.60-0.72%

EQT AB
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

EQT AB is a diversified investment organization with a global footprint, specializing in various sectors including real estate, life sciences, and both private and public equity markets. Through its EQT Exeter division, the company has established itself as a prominent entity in real estate investment management, boasting over $45 billion in total property gross asset value since its inception. This division focuses on delivering value-add, core-plus, and core investment returns for a sophisticated institutional client base that includes pension funds, sovereign wealth funds, and family offices, among others. In the life sciences sector, EQT Life Sciences (formerly known as LSP) positions itself as one of Europe’s leading healthcare investors, with a 30-year history of investing in over 150 private companies and raising more than €3 billion. This branch is dedicated to funding innovative companies in the healthcare and life sciences industries, leveraging a team with deep expertise in medicine, science, and industry. Additionally, EQT Future targets mature market leaders with strong profitability and cash generation, focusing on creating impact within Climate & Nature and Health & Wellbeing sectors. Meanwhile, EQT Public Value adopts a private equity approach to public markets, concentrating on building significant influence positions in Northern European mid-cap publicly-listed companies, aiming to unlock their full potential. Across these diverse platforms, EQT AB employs a strategic approach to investment, combining sector knowledge, analytical skills, and a commitment to driving value and impact.

Summarized from source with an LLMView SourceSector: Business Services

Revenue and Sales Volume

In the third quarter of 2024, EQT AB reported a total sales volume of 581 billion cubic feet equivalent (Bcfe), marking an increase from 523 Bcfe in the same period of 2023. The average realized price per thousand cubic feet equivalent (Mcfe) was $2.38, up from $2.28 in the previous year. This increase in sales volume and pricing contributed to the company's revenue performance for the quarter.

Net Income and Earnings Per Share

EQT AB experienced a net loss of $301 million in the third quarter of 2024, a significant decline from a net income of $81 million in the same quarter of 2023. The diluted loss per share was $0.54, compared to an income of $0.20 per share in the previous year. This downturn in net income and earnings per share reflects the financial challenges faced by the company during this period.

Adjusted Financial Metrics

Despite the net loss, EQT AB reported an adjusted net income of $69 million for the third quarter of 2024, down from $126 million in the same period of 2023. The adjusted earnings per share were $0.12, compared to $0.30 in the previous year. Adjusted EBITDA showed a positive trend, increasing to $832 million from $521 million in the third quarter of 2023.

Cash Flow and Capital Expenditures

Net cash provided by operating activities for EQT AB in the third quarter of 2024 was $593 million, up from $455 million in the same period of 2023. However, capital expenditures increased to $558 million from $445 million in the previous year. The company's free cash flow was negative at $121 million, compared to a negative $2 million in the third quarter of 2023.

Outlook and Guidance

Looking ahead to the fourth quarter of 2024, EQT AB has provided guidance for total sales volume to be between 555 and 605 Bcfe. The company also anticipates capital expenditures to range from $630 million to $730 million. This guidance reflects EQT AB's strategic focus on maintaining production levels and managing capital investments effectively.

Summarized from source with an LLMView Source

Key figures

8.23%1Y

-38.5%3Y

182%5Y

Performance

34.8%1Y

45.7%3Y

48.6%5Y

Volatility